Shari L O'Quinn Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Shari L O'Quinn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Shari L O'Quinn. Shari L O'Quinn is VP, Clinical & Regulatory in ENDOLOGIX INC /DE/ ($ELGX) and VP Clinical/Regulatory Affairs in TriVascular Technologies, Inc. ($TRIV).
Latest Insider Trading Transactions of Shari L O'Quinn
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 06 2017 | ELGX | ENDOLOGIX INC /DE/ | O'Quinn Shari L | VP, Clinical & Regu ... | Option Exercise | A | 4.82 | 65,000 | 313,300 | 65,000 | |
| Jun 06 2017 | ELGX | ENDOLOGIX INC /DE/ | O'Quinn Shari L | VP, Clinical & Regu ... | Grant | A | 0.00 | 18,000 | 0 | 94,356 | 76.4 K to 94.4 K (+23.57 %) |
| Dec 13 2016 | ELGX | ENDOLOGIX INC /DE/ | O'Quinn Shari L | VP, Clinical & Regu ... | Grant | A | 0.00 | 21,834 | 0 | 76,356 | 54.5 K to 76.4 K (+40.05 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Option Exercise | M | 2.43 | 41,838 | 101,666 | 0 | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Option Exercise | M | 0.00 | 9,400 | 0 | 0 | |
| Feb 04 2016 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Sell | D | 0.00 | 23,746 | 0 | 0 | 23.7 K to 0 (-100.00 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Payment of Exercise | F | 5.62 | 18,092 | 101,677 | 23,746 | 41.8 K to 23.7 K (-43.24 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Buy | M | 2.43 | 41,838 | 101,666 | 41,838 | 0 to 41.8 K |
| Feb 04 2016 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Sell | D | 0.00 | 5,851 | 0 | 0 | 5.9 K to 0 (-100.00 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Payment of Exercise | F | 5.62 | 3,549 | 19,945 | 5,851 | 9.4 K to 5.9 K (-37.76 %) |
| Feb 04 2016 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Buy | M | 0.00 | 9,400 | 0 | 9,400 | 0 to 9.4 K |
| Mar 02 2016 | ELGX | ENDOLOGIX INC /DE/ | O'Quinn Shari L | VP, Clinical & Regu ... | Sell | S | 0.00 | 4,000 | 0 | 54,522 | 58.5 K to 54.5 K (-6.84 %) |
| Mar 02 2016 | ELGX | ENDOLOGIX INC /DE/ | O'Quinn Shari L | VP, Clinical & Regu ... | Buy | J | 0.00 | 18,681 | 0 | 58,522 | 39.8 K to 58.5 K (+46.89 %) |
| Feb 05 2016 | ELGX | ENDOLOGIX INC /DE/ | O'Quinn Shari L | VP, Clinical & Regu ... | Option Exercise | A | 7.53 | 86,957 | 654,786 | 86,957 | |
| Feb 05 2016 | ELGX | ENDOLOGIX INC /DE/ | O'Quinn Shari L | VP, Clinical & Regu ... | Grant | A | 0.00 | 39,841 | 0 | 39,841 | 0 to 39.8 K |
| Mar 04 2015 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Option Exercise | A | 10.94 | 17,700 | 193,638 | 17,700 | |
| Mar 04 2015 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Option Exercise | A | 0.00 | 9,400 | 0 | 9,400 | |
| Apr 17 2014 | TRIV | TriVascular Techno ... | O'Quinn Shari L | VP Clinical/Regulat ... | Option Exercise | A | 12.00 | 27,800 | 333,600 | 27,800 |
Page: 1